Through December 31, 2010
Female MS Volunteers Needed for Research Study
Mayo Clinic Arizona is looking for women with relapsing-remitting MS
for a 24 -month study to see if there are less relapses with the treatment of
Copaxone injections plus oral estriol as compared to the treatment of Copaxone
injections plus oral placebo. Estriol is an estrogen of pregnancy that may play
a role in the natural remission of MS during pregnancy.
If you are interested, call Irene Galasky, the study
coordinator, at (480)301-6104 or email
(Galasky.Irene@mayo.edu) for further information.
This trial is funded by the National Multiple Sclerosis
Society and the National Institutes of Health.